课题基金 / 基金详情

"Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer"

"Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer"
“中性粒细胞弹性蛋白酶与特发性肺纤维化和肺癌有关”
批准号:
8490423
负责人:
A McGarry Houghton
金额:
$40.8万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2016-12-31

项目摘要

项目成果

A McGarry Houghton的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肺癌和特发性肺纤维化(IPF)是相关疾病,IPF患者患肺癌的风险增加7倍。这两种疾病的特点都是患者预后差,缺乏有效的疾病改善疗法。常见疾病进展物质的鉴定可能产生新的治疗靶点。我们建议嗜中性粒细胞衍生的丝氨酸蛋白酶,中性粒细胞弹性蛋白酶(NE),是这样一个目标。NE通过类似的机制驱动小鼠模型中肺腺癌和肺纤维化的疾病进展。NE以两种不同的方式分别影响癌症和纤维化中的靶细胞,即肿瘤细胞和成纤维细胞。首先,NE诱导肿瘤细胞和成纤维细胞增殖。第二,NE改变肿瘤细胞和成纤维细胞的行为,产生肿瘤细胞上皮向间质转化(EMT),并驱动肌成纤维细胞分化。这两个过程都与肺癌和IPF背景下的晚期疾病密切相关。该提案将确定NE诱导细胞增殖和改变细胞行为的机制,希望确定这两种疾病共同的新治疗靶点。此外,这些研究应验证NE本身作为肺癌和/或IPF患者的有效治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Lung cancer and idiopathic pulmonary fibrosis (IPF) are linked diseases, with IPF patients being at a seven-fold increased risk of lung cancer. Both of these diseases can be characterized by dismal patient outcomes and the lack of effective disease modifying therapies. The identification of common disease progressing substances may yield novel therapeutic targets. We propose that the neutrophil-derived serine proteinase, neutrophil elastase (NE), is such a target. NE drives disease progression of both lung adenocarcinoma and lung fibrosis in mouse models via similar mechanisms. NE impacts the target cell in cancer and fibrosis, the tumor cell and fibroblast, respectively, in two distinct ways. First, NE induces tumor cell and fibroblast proliferation. Second, NE alters the behavior of tumor cells and fibroblasts, generating tumor cell epithelial to mesenchymal transition (EMT), and driving myofibroblast differentiation. Both of these processes are intimately linked to advanced disease in the setting of lung cancer and IPF. This proposal will identify the mechanisms by which NE induces cell proliferation and alters cell behavior in hopes to identify novel therapeutic targets common to both diseases. Additionally, these studies should validate NE itself, as a valid therapeutic target for patients inflicted with lung cancer and/or IPF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
  • 批准号:
    10717448
  • 项目类别:
  • 资助金额:
    $57.31万
  • 财政年份:
    2023
  • 负责人:
    A McGarry Houghton
  • 依托单位:
Anxa2 drives the function of immune suppressive neutrophils in lung cancer
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
  • 批准号:
    10301566
  • 项目类别:
  • 资助金额:
    $66.03万
  • 财政年份:
    2021
  • 负责人:
    A McGarry Houghton
  • 依托单位:
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
  • 批准号:
    10700944
  • 项目类别:
  • 资助金额:
    $38.98万
  • 财政年份:
    2021
  • 负责人:
    A McGarry Houghton
  • 依托单位:
海外基金